News

 

 

Thyroid Cancer-Rising Most Rapidly Among Insured Patients

Study Points to Over Diagnosis as the Factor

July 01, 2013
Lebanon, NH

The rapid increase in papillary thyroid cancer in the US, may not be linked to increase in occurrence, according to a head and neck surgeon at Dartmouth-Hitchcock Norris Cotton Cancer Center, instead it may be linked to an increase in the diagnosis of pre-cancerous conditions and to a person's insurance status. That is the conclusion of a paper published in Thyroid, a peer reviewed journal of the American Thyroid Association, which included the research of Senior Author Louise Davies, MD, MS, The Veteran's Administration Outcomes Group, White River Junction, Geisel School of Medicine at Dartmouth, and assistant professor of Surgery of The Dartmouth Institute.

"This work shows that access to health care is an important driver in the rising incidence of thyroid cancer," said Davies. "People with insurance are more likely to be diagnosed with thyroid cancer than those without insurance."  In addition researchers found that higher education levels and higher rates of white collar employment were also associated with increased diagnosis rates.

Papillary thyroid cancer is rising 8.8 percent in Americans over age 65 who have Medicare. Among adults under age 65, who do not have access to Medicare, the rate of increase is 6.4 percent. The mortality rate from thyroid cancer, however, has not changed.

"We did the study to understand who is at risk of being diagnosed with thyroid cancer, which is now— like prostate cancer—recognized to be a disease that is commonly over diagnosed," said Davies.

Over diagnosis is the identification of a cancer that would otherwise not have been identified in a person's lifetime.

"The findings are counterintuitive for many: having good health insurance puts you at risk for something bad—the unnecessary identification and treatment of a cancer that was never destined to cause a problem," said Davies.

Davies and lead author Luc Morris, MD, MSc, Memorial Sloan-Kettering Cancer Center, used Surveillance, Epidemiology and End Results (SEER) data to examine papillary thyroid cancer incidence trends in Medicare age and non-Medicare age adults over three decades. They looked at 497 counties in the US over three decades. The Geospatial Shared Resource at Norris Cotton Cancer Center helped the team analyze and map the information.

How will this finding change the practice of medicine? According to Davies, "As a next step we should look to protect patients from unnecessary workups of thyroid findings that do not present a significant threat to their health."

More on Over Diagnosis

The Dartmouth Institute for Health Policy & Clinical Practice, in partnership with one of the world's most respected medical journals, the BMJ, the leading New-York based consumer organization Consumer Reports, and Bond University  will present The Preventing Overdiagnosis conference on  September 10-12,  2013. For more information, visit  http://www.preventingoverdiagnosis.net/

About Norris Cotton Cancer Center at Dartmouth-Hitchcock

Norris Cotton Cancer Center combines advanced cancer research at Dartmouth College and the Geisel School of Medicine at Dartmouth College with patient-centered cancer care provided at Dartmouth-Hitchcock Medical Center, at Dartmouth-Hitchcock regional locations in Manchester, Nashua, and Keene, NH, and St. Johnsbury, VT, and at 12 partner hospitals throughout New Hampshire and Vermont. It is one of 41 centers nationwide to earn the National Cancer Institute's "Comprehensive Cancer Center" designation. Learn more about Norris Cotton Cancer Center research, programs, and clinical trials online at cancer.dartmouth.edu.

For more information contact Donna Dubuc at (603) 653-3615.

Back to News